Clik here to view.
Spectrum Pharmaceuticals Highlights Poziotinib Data in Non-Small-Cell Lung...
HENDERSON, Nev. Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and...
View ArticleClik here to view.
Second Sight Announces Appointments of Frank Vandeputte as Vice President and...
SYLMAR, Calif. Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that provide useful...
View ArticleClik here to view.
Median Technologies Appoints Vivian Wang as General Manager, China and...
SOPHIA ANTIPOLIS, France Regulatory News: Median Technologies (Paris:ALMDT), The Imaging Phenomics Company® today announces the appointment of Vivian Wang as General Manager, China and the...
View ArticleClik here to view.
New Data Demonstrate VTI’s Multifocal Contact Lenses Effective in Reducing...
ATLANTA, Ga. Visioneering Technologies, Inc. (ASX:VTI) today announced the positive results of a new retrospective case series analysis on the impact of its NaturalVue® Multifocal 1 Day Contact...
View ArticleClik here to view.
Zebra Medical Vision要让人人都能容易地取得更加经济实惠的人工智能医疗照护
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 纽约 深度学习影像分析的领导企业Zebra Medical...
View ArticleClik here to view.
グラミネックス、臨床研究の論文発表を受けてIDIPharmaとの提携を拡大
米ミシガン州サギノー （ビジネスワイヤ） — 溶剤不使用グラミネックス花粉エキスを生産するグラミネックス（Graminex®...
View ArticleClik here to view.
GRAMINEX L.L.C.在临床研究发表后扩大与IDIPharma的伙伴关系
密歇根州萨基诺 (美国商业资讯) — 无溶剂Graminex® Flower Pollen Extract™的生产商Graminex® LLC欣然宣布扩大与IDIPharma的伙伴关系。支持Graminex® Flower Pollen Extract™用于前列腺疼痛及慢性盆腔疼痛(CPP)的多项临床研究完成并发表后，IDIPharma与Graminex®一致同意扩大Graminex®...
View ArticleClik here to view.
Median Technologies Adds MediScan® To Its Product Portfolio
SOPHIA ANTIPOLIS, France Regulatory News: This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171031006142/en/ Median Technologies...
View ArticleClik here to view.
MedAdvisor to Expand into Hospitals as EBOS Invests $9.5M at $0.0575 Per Share
MELBOURNE, Australia MedAdvisor (ASX:MDR), Australia’s leading digital medication management company, announces a $9.5 million strategic investment by one of Australasia’s leading healthcare...
View ArticleClik here to view.
Takeda Reports First Half FY2017 Results
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue growth of 6.7% led by Takeda’s Growth Drivers Underlying Revenue grew +6.7% with solid performances across all...
View ArticleClik here to view.
武田薬品：2017年度上期（4-9月期）の連結業績について
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社 （東証：4502）： 実質的な売上収益は＋6.7％の増収、タケダの成長ドライバーが牽引...
View ArticleClik here to view.
Kansai Paint Announces Its Exhibit at MEDICA2017, the World’s Largest Medical...
OSAKA, Japan Kansai Paint Co., Ltd. (Head office: Osaka, President: Hiroshi Ishino) will exhibit at “MEDICA 2017″ Dusseldorf, Germany from Monday, November 13 to Thursday, November 16. “MEDICA” is...
View ArticleClik here to view.
Otsuka Announces Phase 3 Results for Tolvaptan in Patients with Autosomal...
TOKYO Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced detailed results from the Phase 3 REPRISE trial of tolvaptan, which is under investigation in the United States in patients with...
View ArticleClik here to view.
武田药品工业株式会社公布2017年上半年业绩
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited)(TOKYO:4502)： 武田增长引擎带动基础营收增长了6.7% 基础营收增长+6.7%，各地区业务均斩获了不俗的业绩（美国+16.7%、日本 +0.3%、欧洲与加拿大 +4.2%、 新兴市场...
View ArticleClik here to view.
Alexion Receives New Japanese Patent for Soliris® (eculizumab), Extending...
NEW HAVEN, Conn. Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) announced today that the Japanese Patent Office (JPO) has issued patent No. 6224059, directed to the composition of matter of eculizumab...
View ArticleClik here to view.
Takeda and Portal Instruments Announce Collaboration to Develop Needle-Free...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda Pharmaceutical Company Limited (TSE: 4502) and Portal Instruments today announced a collaboration to develop and commercialize Portal’s needle-free drug...
View ArticleClik here to view.
Sterigenics International LLC Changes Name to Sotera Health LLC
CLEVELAND Sterigenics International LLC (the “Company”) announced today that it has changed its parent company name to Sotera Health LLC. Its three operating companies – Nelson Labs™, Nordion® and...
View ArticleClik here to view.
Sonitor® and ZulaFly Partner with Life Care, Inc. to Break New Ground in...
STAMFORD, Conn. Sonitor announced today that Life Care, Inc., a long-term care network located in South Australia, has deployed their RTLS platform at Life Care’s Reynella facility. This RTLS...
View ArticleClik here to view.
FDNA Expands into Asia-Pacific Markets
BANGKOK (APSHG Conference) – FDNA, developer of Face2Gene, today announces expansion of its growing presence in the Asia-Pacific region with the launch of its new Center of Research Excellence at...
View ArticleClik here to view.
Progenity宣布完成1.25亿美元融资，用于产前-女性健康遗传学和胃肠病/炎性肠病精准医学
圣迭戈 (美国商业资讯) — 私营生物技术公司Progenity Inc.今天宣布完成一笔包含资产和债务的价值1.25亿美元的私募B轮融资。该融资由其现有的投资者之一Athyrium Capital Management掌管的一家基金领投。 Progenity Inc.执行董事长、创始人Harry...
View Article